Shuttle Pharma Provides Second Quarter 2024 Corporate Update
GAITHERSBURG, Md., Sept. 04, 2024 ( GLOBE NEWSWIRE ) -- Shuttle Pharmaceuticals Holdings, Inc. ( Nasdaq: SHPH ) ( "Shuttle Pharma" ) , a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy ( RT ) , ...
| Ticker |
Sentiment |
Impact |
|
APG
|
Neutral
|
4 %
|
|
SHPH
|
Neutral
|
11 %
|
